Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Sonoma Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +6 vs. Q2 2025
- Shares held
- 59.4K
- −25.5K (−30.1%) vs. Q2 2025
- Total value
- $230.3K
- −$11.7K (−4.8%) vs. Q2 2025
- New holders
- 8
- 2 more added
- Sold out
- 2
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNOA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $136.3K |
| Q1 2026 | 17 | $143.7K |
| Q4 2025 | 16 | $396.4K |
| Q3 2025 | 20 | $230.3K |
| Q2 2025 | 14 | $242.0K |
| Q1 2025 | 12 | $71.5K |
| Q4 2024 | 9 | $54.2K |
| Q3 2024 | 14 | $85.2K |
| Q2 2024 | 20 | $91.7K |
| Q1 2024 | 16 | $27.3K |
| Q4 2023 | 17 | $54.8K |
| Q3 2023 | 13 | $97.3K |
| Q2 2023 | 16 | $175.0K |
| Q1 2023 | 18 | $143.5K |
| Q4 2022 | 15 | $159.3K |
| Q3 2022 | 17 | $396.0K |
| Q2 2022 | 18 | $540.0K |
| Q1 2022 | 18 | $687.0K |
| Q4 2021 | 18 | $806.0K |
| Q3 2021 | 21 | $1.19M |
| Q2 2021 | 21 | $1.56M |
| Q1 2021 | 19 | $1.32M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Sonoma Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $4 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1 | $4 | 0.00% | +1 | New |
| FMR LLC | 2 | $7 | 0.00% | +2 | New |
| Allworth Financial LP | 3 | $12 | 0.00% | 00.0% | Unchanged |
| Quaker Wealth Management, LLC | 3 | $12 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4 | $16 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 17 | $66 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 25 | $97 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 108 | $419 | 0.00% | −14,309−99.3% | Reduced |
| BlackRock, Inc. | 113 | $438 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 123 | $477 | 0.00% | +3+2.5% | Added |
| MAI Capital Management | 124 | $482 | 0.00% | +124 | New |
| Global Retirement Partners, LLC | 438 | $1.70K | 0.00% | +438 | New |
| Rockefeller Capital Management L.P. | 646 | $2.51K | 0.00% | +646 | New |
| Citigroup Inc | 656 | $2.54K | 0.00% | +656 | New |
| Tower Research Capital LLC (TRC) | 1,536 | $5.96K | 0.00% | +536+53.6% | Added |
| DRW Securities, LLC | 17,070 | $66.2K | 0.00% | +17,070 | New |
| Geode Capital Management, LLC | 17,617 | $68.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 20,873 | $81.0K | 0.00% | +20,873 | New |
| Heron Bay Capital Management | 0 | $0 | 0.00% | −33,782−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,800−100.0% | Sold out |